Research Paper Volume 16, Issue 9 pp 7818—7844
Unraveling the unfolded protein response signature: implications for tumor immune microenvironment heterogeneity and clinical prognosis in stomach cancer
Figure 11. The UPR-related predictive signature for stomach cancer patients in different clinical subgroups. The KM curve for stomach cancer patients with (A) age≤65, (B) age>65, (C) Female, (D) Male, (E) Grade 1, (F) Grade 2, (G) Grade 3, (H) M0 stage, (I) M1 stage, (J) N0 stage, (K) N1+N2+N3 stage, (L) Stage I, (M) Stage II, (N) Stage III, (O) Stage IV, (P) T1 stage, (Q) T2 stage, (R) T3 stage, (S) T4 stage.